Navigation Links
Cardium Announces Plans to File FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Gel for Diabetic, Pressure and Venous Ulcers and Other Topical Wounds
Date:11/2/2009

ll perform as anticipated.

Actual results may also differ substantially from those described in or contemplated by this press release due to risks and uncertainties that exist in our operations and business environment, including, without limitation, risks and uncertainties that are inherent in the development of complex biologics and in the conduct of human clinical trials, including the timing, costs and outcomes of such trials, our ability to obtain necessary funding, regulatory approvals and expected qualifications, our dependence upon proprietary technology, our history of operating losses and accumulated deficits, our reliance on collaborative relationships and critical personnel, and current and future competition, as well as other risks described from time to time in filings we make with the Securities and Exchange Commission. We undertake no obligation to release publicly the results of any revisions to these forward-looking statements to reflect events or circumstances arising after the date hereof.

Copyright 2009 Cardium Therapeutics, Inc. All rights reserved.

For Terms of Use Privacy Policy, please visit www.cardiumthx.com.

Cardium Therapeutics(TM) and Generx® are trademarks of Cardium Therapeutics, Inc.

Tissue Repair(TM), Gene Activated Matrix(TM), GAM(TM), Excellagen(TM), Excellarate(TM) and Osteorate(TM) are trademarks of Tissue Repair Company.

SOURCE Cardium Therapeutics


'/>"/>
SOURCE Cardium Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Cardium Completes $6.0 Million Registered Direct Offering
2. Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors
3. Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications
4. Cardium Regains Listing Compliance with NYSE Amex
5. Cardiums InnerCool Therapies Business to Be Acquired By Royal Philips Electronics
6. Cardium Announces Conference Call and Webcast to Review Recent Developments and Future Plans for the Excellarate(TM) Clinical Development Program
7. FDA has Granted HUD (Humanitarian Use Device) Designation to ITGIs Pericardium Covered Stents, Over and Under(R) and Aneugraft(R), for Treatment of Perforations and Dissections of Native Coronary Arteries and Saphenous Vein Grafts
8. Cardium Completes $3.5 Million Credit Facility
9. Cardium Announces Retirement of Director
10. Cardiums InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study
11. Cardiums InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... , NANJING, China, Dec. 2 /PRNewswire-As...the "Company") (NYSE: SCR ), a leading pharmaceu...ufacturing, and marketing of branded,generic and p...ed that 105 of,its drugs have been included in Chi...ich was issued by China,s Ministry of Human Resour...
(Date:12/2/2009)... , SHANGHAI, Dec. 2 /PRNewswire-Asia/ --...arkets are in turmoil and uncertainty is part of m...he pharma industry has been,relatively immune to t... a,vacation. , During the midst of the di...Johnson & Johnson inaugurated an R&D cente...
(Date:12/2/2009)... , HOBOKEN, N.J., Dec. 2 Accor...nt to 45 percent of Americans diagnosed with diabe...y. Diabetic retinopathy, damage to the retina cau...indness in people with diabetes and is one of the ...o 80 percent of all patients who,ve had diabetes f...
(Date:12/1/2009)..., INCLINE VILLAGE, Nev., Dec. 1 /PRNewswire-Fir...I ) today announced revenue guidance for the fourt... $57 million, as compared with $69 million for the...r 2008 results was the first of two installment pa...ed in fourth quarter 2008 results was a one-time $...
Breaking Biology Technology:Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3
...r Enabling Faster, Easier,Quantification of Protei...e Clinical Trials, WAL...),a leading developer of protein biomarker analysi...ent, today announced the company,s,PATH(R) technol...7 by the,U.S. Patent and Trademark Office. The pat...
...D), an industry-leading provider of Computer-Aided...ation of cancer, today announced that two,U.S. Pat...ly been granted,to the Company by the United State...nts demonstrate our on-going commitment to broaden...represent an important,addition to our portfolio o...
...osclerosis enters the clinic ...ewswire-FirstCall/ - Resverlogix Corp.,("Resverlog...d approval by,the US Food and Drug Administration ...l RVX-208 in the USA. RVX-208 is a novel first-in-... of ApoA-I and HDL. ApoA-I is,regarded as the crit...
Other Biology Technology:Decision Biomarkers Awarded U.S. Patent for Protein Array Surface Chemistry 2iCAD, Inc. Awarded Two Additional Patents for Its Computer-Aided Detection Technology 2iCAD, Inc. Awarded Two Additional Patents for Its Computer-Aided Detection Technology 3FDA Grants Resverlogix Approval to Commence a Phase 1 Clinical Trial for RVX-208 2FDA Grants Resverlogix Approval to Commence a Phase 1 Clinical Trial for RVX-208 3
(Date:12/2/2009)...cientist from the University of Salamanca and anot...nce of predators affects the behaviour of Acantho... Negev Desert in the Near East. According to the s...le and different prey if they are under pressure f...dicted this result, but until now there had been v...
(Date:12/1/2009)...ber 1, 2009: OptiNose is pleased to announce the p...tudy investigating the efficacy and tolerability o...e topical treatment of chronic rhinosinusitis with... of the International and European Rhinologic Soci...ps is a chronic disease that can significantly red...
(Date:12/1/2009)... Georgia Institute of Technology has been awarded ...nostructures for energy harvesting and adaptive ma... cognitive processes of the modern warfighter. ,...enabled Inorganic/Organic Nanostructures and Impro...dimir Tsukruk and Kenneth Sandhage, professors in ...
Breaking Biology News(10 mins):Lizards change their diet to avoid predators 2New data on highly effective treatment for chronic rhinosinusitis with nasal polyps 2Air Force Center of Excellence awarded in nanostructures and improved cognition 2Air Force Center of Excellence awarded in nanostructures and improved cognition 3Air Force Center of Excellence awarded in nanostructures and improved cognition 4BRIT1 allows DNA repair teams access to damaged sites 49483 1BRIT1 allows DNA repair teams access to damaged sites 49483 2Dysport Available 21 New Wrinkle Treatment in Washington DC Offers Botox Alternative 49480 1Dysport Available 21 New Wrinkle Treatment in Washington DC Offers Botox Alternative 49480 2Highmark Program Receives Top Community Leadership Award 49477 1Highmark Program Receives Top Community Leadership Award 49477 2
...Foundation has announced the award of $263,274 to ...upport her work in exploring the structure, functi...n one of the most important marine primary produce...thetic Response to Abiotic Stress in Prochlorococc...t addresses the remarkable differences in genomes ...
...is working to develop a quick, simple and cheap im...d. It could help HIV/AIDS sufferers in the poorest...ir lives, possibly by as much as 10 to 15 years. ,... consortium, called the CD4 Initiative, led by Imp... Melinda Gates Foundation. Antje J. Baeumner, Corn...
...hing for new methods and therapies to reduce infar... in patients who experience myocardial infarction ...day at the American College of Cardiology’s Innova...., a team from the Duke Clinical Research Institut...ating a novel protein kinase C inhibitor that had ...
Other Biology News:Williams College biologist explores photosynthetic apparatus 2Cornell researcher helping develop quick, cheap HIV/AIDS test 2Protein therapy may reduce infarct size in heart attack patients 2
...isION Ion Channel Cell Lines ,High Quality, Functi...annels are well known for having a critical role i...a key function in pain, CNS and the heart. Drugs t...n therapeutic areas, such as neuropathic pain, car...
Mouse Anti-Human SLC25A11 Monoclonal Antibody, Unconjugated, Clone 3G4 from Abnova Corporation
Mouse Anti-TOPORS Monoclonal Antibody, Unconjugated, Clone 4G4 from Abnova Corporation
Mouse Anti-Human SNAPC5 Monoclonal Antibody, Unconjugated, Clone 6G10 from Abnova Corporation
Biology Products: